Patent Law Weblog
recent posts
- Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
about
Month: August 2009
-
By Donald Zuhn — President Obama Wants to Speed Up Introduction of Generic Drugs In a health care town hall meeting held in Portsmouth, NH last week, President Obama told attendees that he wanted to speed up the introduction of generic drugs into the marketplace. His comment came during an exchange with a man…
-
By Suresh Pillai — Settlement Announced in University of Iowa Dispute with Amgen The University of Iowa Research Foundation (UIRF) has announced a settlement in its dispute with Amgen Inc. over alleged patent infringement of two UIRF patents covering a cytomegalovirus promoter used in the design and manufacture of a number of marketed vaccines…
-
By Donald Zuhn — Last week, the Biotechnology Industry Organization (BIO) and Thomson Reuters released the results of an investor perception study conducted earlier this year that correctly forecast a rebound for the biotech industry. A 37-page report outlining the result of the study can be obtained here. Patent Docs initially reported on this…
-
By Donald Zuhn — Last week, CNBC anchor Joe Kernen challenged Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood over the wisdom of implementing a follow-on biologics (FOB) regulatory pathway that provides innovator biologics manufacturers with 12 years of exclusivity. Mr. Greenwood, however, was up to the challenge, as he explained why a…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Astrazeneca LP et al. v. Breath Ltd.1:09-cv-04115; filed August 12, 2009 in the District Court of New Jersey • Plaintiffs: Astrazeneca LP;…
-
August 17-18, 2009 – Advanced Patent Prosecution Workshop 2009: Claim Drafting & Amendment Writing (Practising Law Institute) – San Francisco, CA September 1, 2009 – Prior Art & Obviousness 2009: The PTO & CAFC Perspective on Patent Law Sections 102 & 103 (Practising Law Institute) – San Francisco, CA September 13-15, 2009 – 2009 Annual…
-
The Center for Business Intelligence (CBI) will be holding its 2nd Annual Pharmaceutical Congress on Paragraph IV Disputes and Settlements on October 22-23, 2009 in Philadelphia, PA. The conference will cover issues relevant to both brand and generic companies during two days of presentations and panel discussions on litigation strategies, statutory guidelines, current cases, and…
-
The Biotechnology Industry Organization (BIO) will be holding its Intellectual Property Counsels' Committee (IPCC) Fall Conference & Meeting on October 26-28, 2009 in Washington, DC. The semi-annual IPCC conference will once again be open to the public. The conference will offer presentations on the following topics: Tuesday, October 27: • Patent re-examination;• Federal Circuit case…
-
Practising Law Institute (PLI) will be holding five sessions of its Patent Litigation 2009 seminar this fall in San Francisco (September 21-22), McLean, VA (October 5-6), Chicago (October 15-16), Atlanta (November 9-10), and New York (November 16-17). Each session of the Patent Litigation 2009 seminar will offer presentations on the following topics: • Recent developments…
-
By Kevin E. Noonan — The Biotechnology Industry Organization (BIO) filed an amicus brief with the Supreme Court last week in Bilski v. Doll, the appeal from the Federal Circuit's en banc decision establishing the "machine or transformation" test as the exclusive test for patent eligibility of process claims. BIO was joined on the…
Patent Docs 